Last reviewed 2026-05-13 · How we verify

VAC BNO 1095 film coated tablets

Bionorica SE · Phase 3 active Small molecule

VAC BNO 1095 film coated tablets is a Herbal medicinal product Small molecule drug developed by Bionorica SE. It is currently in Phase 3 development for Immune support and inflammatory conditions (specific indication under Phase 3 evaluation not publicly detailed).

VAC BNO 1095 is a herbal film-coated tablet formulation that modulates immune and inflammatory responses through its botanical active constituents.

VAC BNO 1095 is a herbal film-coated tablet formulation that modulates immune and inflammatory responses through its botanical active constituents. Used for Immune support and inflammatory conditions (specific indication under Phase 3 evaluation not publicly detailed).

At a glance

Generic name	VAC BNO 1095 film coated tablets
Sponsor	Bionorica SE
Drug class	Herbal medicinal product
Modality	Small molecule
Therapeutic area	Immunology / Respiratory / Inflammation
Phase	Phase 3

Mechanism of action

VAC BNO 1095 is a standardized herbal combination product developed by Bionorica SE. The exact mechanism involves multiple plant-derived compounds that work synergistically to support immune function and reduce inflammatory markers. As a botanical drug product, it likely operates through multiple molecular pathways rather than a single target.

Approved indications

Immune support and inflammatory conditions (specific indication under Phase 3 evaluation not publicly detailed)

Common side effects

No common side effects on file.

Key clinical trials

Dose-dependent Effects of VAC BNO 1095 on Cyclic Mastodynia and Premenstrual Syndrome (PHASE3)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

VAC BNO 1095 film coated tablets CI brief — competitive landscape report
VAC BNO 1095 film coated tablets updates RSS · CI watch RSS
Bionorica SE portfolio CI

Frequently asked questions about VAC BNO 1095 film coated tablets

What is VAC BNO 1095 film coated tablets?

VAC BNO 1095 film coated tablets is a Herbal medicinal product drug developed by Bionorica SE, indicated for Immune support and inflammatory conditions (specific indication under Phase 3 evaluation not publicly detailed).

How does VAC BNO 1095 film coated tablets work?

VAC BNO 1095 is a herbal film-coated tablet formulation that modulates immune and inflammatory responses through its botanical active constituents.

What is VAC BNO 1095 film coated tablets used for?

VAC BNO 1095 film coated tablets is indicated for Immune support and inflammatory conditions (specific indication under Phase 3 evaluation not publicly detailed).

Who makes VAC BNO 1095 film coated tablets?

VAC BNO 1095 film coated tablets is developed by Bionorica SE (see full Bionorica SE pipeline at /company/bionorica-se).

What drug class is VAC BNO 1095 film coated tablets in?

VAC BNO 1095 film coated tablets belongs to the Herbal medicinal product class. See all Herbal medicinal product drugs at /class/herbal-medicinal-product.

What development phase is VAC BNO 1095 film coated tablets in?

VAC BNO 1095 film coated tablets is in Phase 3.

Drug class: All Herbal medicinal product drugs
Manufacturer: Bionorica SE — full pipeline
Therapeutic area: All drugs in Immunology / Respiratory / Inflammation
Indication: Drugs for Immune support and inflammatory conditions (specific indication under Phase 3 evaluation not publicly detailed)
Compare: VAC BNO 1095 film coated tablets vs similar drugs
Pricing: VAC BNO 1095 film coated tablets cost, discount & access